Preinvasive Disease of the Vagina and Vulva and Related Disorders

Clinical Gynecologic Oncology

Volumn , Issue , 2007, Pages 37-54

  Creasman, William T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871717228     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032303978-9.50005-8     Document Type: Chapter

References (95)

1. Benedet JL, Wilson PS, Matisic JP Epidermal thickness measurements in VAIN. J Reprod Med 1992, 37:809.
2. Blumberg JM, Ober WB Carcinoma in situ of the cervix: Recurrence in the vaginal vault. Am J Obstet Gynecol 1952, 66:421.
3. Buck HW, Guth KJ Treatment of VAIN (primarily low grades) with Imiquimod 5% cream. J Lower Genital Tract Dis 2003, 7:290-293.
4. Caglar H, Hurtzog RW, Hreshchyshyn MM Topical 5-FU treatment of vaginal intraepithelial neoplasia. Obstet Gynecol 1981, 58:580.
5. Capen CV, et al. Laser therapy of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 1982, 142:973.
6. Carter ER, Salvaggio AT, Jarkowski TL Squamous cell carcinoma of the vagina following vaginal hysterectomy of intraepithelial carcinoma of the cervix. Am J Obstet Gynecol 1961, 82:401.
7. Copenhaver EH, Salzman FA, Wright KA Carcinoma in situ of the vagina. Am J Obstet Gynecol 1964, 89:962.
8. Cromer JK Invasive squamous-cell carcinoma of the vagina following surgery for carcinoma in situ of the cervix. Med Ann DC 1965, 34:115.
9. Diakomanolis E, et al. Treatment of high grade VAIN with Imiquimod cream. N Eng J Med 2002, 347:374.
10. Dungar CF, Wilkinson EJ Vaginal columnar cell metaplasia: An acquired adenosis associated with topical 5-FU therapy. J Reprod Med 1995, 40:361.
11. Ferguson JH, Maclure JG Intraepithelial carcinoma, dysplasia, and exfoliation of cancer cells in the vaginal mucosa. Am J Obstet Gynecol 1963, 87:326.
12. Graham JB, Meigs JV Recurrence of tumor after total hysterectomy for carcinoma in situ. Am J Obstet Gynecol 1952, 64:1159.
13. Gusberg SB, Marshall D. Intraepithelial carcinoma of the cervix: A clinical reappraisal. Obstet Gynecol 1962, 19:713.
14. Jemal A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
15. Koss LG, Melamed MR, Daniel WW In situ epidermoid carcinoma of the cervix and vagina following radiotherapy for cervical cancer. Cancer 1961, 14:353.
16. Krebs HB Treatment of vaginal intraepithelial neoplasia with laser and topical 5FU. Obstet Gynecol 1989, 73:657.
17. Marcus SL Multiple squamous cell carcinoma involving the cervix, vagina, and vulva: The theory of multicentric origin. Am J Obstet Gynecol 1961, 80:801.
18. McPherson HA, et al. Epidermoid carcinoma of cervix, vagina, and vulva: A regional disease. Obstet Gynecol 1963, 21:145.
19. Moran JP, Robinson HJ Primary carcinoma in situ of the vagina. Obstet Gynecol 1962, 20:405.
20. Newman W, Cromer JK The multicentric origin of carcinoma of the female anogenital tract. Surg Gynecol Obstet 1959, 108:273.
21. Noller KL Screening for vaginal cancer (Editorial). N Engl J Med 1996, 335:1599.
22. Ostergard DR, Morton DG Multi-focal carcinoma of the female genitals. Am J Obstet Gynecol 1967, 99:1006.
23. Parker RT Clinical problems of early cervical neoplasia. Obstet Gynecol Survey 1969, 24:684-697.
24. Pearce KF, Haefner HK, Sarwar SF, Nolan SF Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996, 335:1559.
25. Petrilli ES, et al. Vaginal intraepithelial neoplasias: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser. Am J Obstet Gynecol 1980, 138:321.
26. Rutledge F Cancer of the vagina. Am J Obstet Gynecol 1967, 97:635.
27. Samuels B, Bradburn DM, Johnson CG Primary carcinoma in situ of the vagina. Am J Obstet Gynecol 1961, 82:393.
28. Schellhas HF: Personal communication, 1982.
29. Sillman FH, Fruchter RG, Chen YS, et al. Vaginal intraepithelial neoplasia: Risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol 1997, 176:93.
30. Townsend DE, et al. Treatment of vaginal carcinoma in situ with carbon dioxide laser. Am J Obstet Gynecol 1982, 143:565.
31. Woodruff JD Treatment of recurrent carcinoma in situ in the lower genital canal. Clin Obstet Gynecol 1965, 8:757.
32. Fowler WC, et al. Risks of cervical intraepithelial neoplasia among DES-exposed women. Obstet Gynecol 1981, 38:720.
33. Herbst AL, Scully RE, Robboy SJ Problems in examination of the DES-exposed female. Obstet Gynecol 1975, 46:353.
34. Kurman RJ, Scully RE The incidence and histogenesis of vaginal adenosis: An autopsy study. Hum Pathol 1974, 5:265.
35. Ng ABP, et al. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero. J Reprod Med 1977, 18:1.
36. O'Brien PC, et al. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol 1979, 53:300.
37. Robboy SJ, et al. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. JAMA 1984, 252:2979.
38. Sandberg EC The incidence and distribution of occult vaginal adenosis. Am J Obstet Gynecol 1968, 93:209.
39. Ulfelder H, Robboy SJ The embryologic development of the human vagina. Am J Obstet Gynecol 1976, 126:769.
40. Waggoner SE, Mittendorf R, Biney N, et al. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol 1994, 55:238.
41. Bracco EL, Carli P, Sonni L, et al. Clinical and histopathologic effects of topical treatment of vulval lichen sclerosus. J Reprod Med 1993, 38:37.
42. Dalziel KL Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995, 40:35l.
43. Friedrich EG, Julian CG, Woodruff JD Acridine orange fluorescence in vulvar dysplasia. Am J Obstet Gynecol 1964, 90:1281.
44. Friedrich EG Vulvar dystrophy. Clin Obstet Gynecol 1985, 28:178.
45. Friedrich EG, Kalra PS Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N Engl J Med 1984, 310:488.
46. Harrington CI, Dunsmore JR An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981, 104:563.
47. Hart WR, Norris HJ, Helwig EB Relation of lichen sclerosus et atrophicus of vulva to the development of carcinoma. Obstet Gynecol 1975, 45:369.
48. International Society for the Study of Vulvovaginal Disease. J Reprod Med 1998, 43:601.
49. Classification of vulvar lesions: Report of the ISSVD Terminology Committee. Am J Obstet Gynecol 1989, 160:769. International Society for the Study of Vulvovaginal Disease(ISSVD).
50. Jeffcoat TNA Chronic vulva dystrophies. Am J Obstet Gynecol 1966, 95:61.
51. Jeffcoat TNA The dermatology of the vulva. J Obstet Gynaecol Br Comm 1962, 69:888.
52. Kaufman RH, Gardener HL, Brown D, Beyth Y. Vulvar dystrophies: An evaluation. Am J Obstet Gynecol 1974, 120:363.
53. Lorenz B, Kaufman RH, Kutzner SK Lichen sclerosus, therapy with clobetasol propionate. J Reprod Med 1998, 43:790.
54. Wallace HJ Lichen sclerosus et atrophicus. Traus St. Julius Hosp. Dermatol Soc 1971, 57:9.
55. Woodruff JD, Borkowf HI, Holzman GB, et al. Metabolic activity in normal and abnormal vulvar epithelia. Am J Obstet Gynecol 1965, 91:809.
56. Abell MR, Gosling JR Intraepithelial and infiltrative carcinoma of vulva, Bowen's type. Cancer 1961, 14:318.
57. 2 laser for treatment of vulvar carcinoma in situ. Obstet Gynecol 1981, 57:371.
58. Barbero M, Micheletti L, Preti M, et al. Biologic behavior of vulvar intraepithelial neoplasia. J Reprod Med 1993, 38:108.
59. Benedet JL, Wilson PS, Matisic J. Epidermal thickness and skin appendage involvement in VIN. J Reprod Med 1991, 36:608.
60. Bowen JT Precancerous dermatoses. J Cutan Dis 1912, 30:241.
61. Carson TE, Hoskins WJ, Wurzel JF Topical 5-fluorouracil in the treatment of carcinoma in situ of the vulva. Obstet Gynecol 1976, 47(Suppl):59.
62. Chafe W, Richards A, Morgan L, et al. Unrecognized invasive carcinoma in VIN. Gynecol Oncol 1988, 31:154.
63. Christopher J, Kaufman RH Treatment of VIN 2/3 with imiquimod. J Reprod Med 2002, 47:395-398.
64. Colgan TJ Vulvar intraepithelial neoplasia: A synopsis of recent developments. J Lower Genital Tract Dis 1998, 2:31.
65. Collin CG A clinical stain for use in selecting biopsy sites in patients with vulvar diseases. Obstet Gynecol 1966, 28:158.
66. Costa S, Syrjanen S, Vendra C, et al. Human papillomavirus infections in vulval precancerous lesions and cancer. J Reprod Med 1995, 40:291.
67. Crum CP, et al. Vulvar intraepithelial neoplasia: Correlation of nuclear DNA content in the presence of human papilloma virus (HPV) structural antigen. Cancer 1982, 49:468.
68. Friedrich EG Reversible vulvar atypia. Obstet Gynecol 1972, 39:173.
69. Friedrich EG Vulvar carcinoma in situ in identical twins-an occupational hazard. Obstet Gynecol 1972, 39:837.
70. Higgins RV, Van Nagell JR, Donaldson ES, et al. The efficacy of laser therapy in the treatment of cervical intraepithelial neoplasia. Gynecol Oncol 1990, 36:79.
71. Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia. J Reprod Med 1996, 41:665. Italian Study Group in Vulvar Disease.
72. Jones RW, McLean MR CIS of vulva: A review of 31 treated and 5 untreated cases. Obstet Gynecol 1986, 68:499.
73. Jones RW, Park JS, McLean MR, et al. Human papilloma virus in women with VIN III. J Reprod Med 1990, 35:1124.
74. Kagie MJ, Kenter GG, Hermans J, et al. The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva. Int J Gynecol Cancer 1997, 7:50.
75. Krupp PJ, Bohm JW 5-Fluorouracil topical treatment of in situ vulvar cancer. Obstet Gynecol 1978, 51:702.
76. Litwin MS, et al. Topical chemotherapy of lentigo maligna with 5-fluorouracil cream. J Surg Oncol 1975, 35:721.
77. Marchitelli C, Secco G, Perrotta M, et al. Treatment of bowenoid and basaloid VIN 2/3 with imiquimod 5% cream. J Reprod Med 2004, 49:876-882.
78. McNally OM, Mulvany NJ, Pagano R, et al. VIN 3: A clinicopathologic review. In J Gynecol Can 2002, 12:490-495.
79. Miller BE VIN treated with cavitational ultrasonic surgical aspiration. Gynecol Oncol 2002, 85:114-118.
80. Modesitt SC, Waters AB, Walton L, et al. Vulvar intraepithelial neoplasia III: Occult cancer and the impact of margin status on recurrence. Obstet Gynecol 1998, 92:962.
81. Raaf JH, et al. Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil. Cancer 1976, 37:1633.
82. Reid R Superficial laser vulvectomy. Am J Obstet Gynecol 1985, 152:504.
83. New nomenclature for vulvar disease. Am J Obstet Gynecol 1989, 160:769. Report of the Committee on Terminology.
84. Richart RM A clinical staining test for the in vivo delineation of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1963, 86:703.
85. Rodolakis A, Diakomanolis E, Vlachos G, et al. VIN-diagnostic and therapeutic challenges. Eur J Gynaecol Oncol 2003, 24:317-322.
86. Rutledge F, Sinclair M. Treatment of intraepithelial carcinoma of the vulva by skin excision and graft. Am J Obstet Gynecol 1968, 102:806.
87. 2 laser used for carcinoma in situ/Bowen's disease (VIN) and lichen sclerosus in the vulvar region. Acta Obstet Gynecol Scand 1989, 68:551.
88. Sturgeon SS, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992, 166:1482.
89. Sykes P, Smith N, McCormick P, et al. High grade VIN. A retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust NZ J Obstet Gynaecol 2002, 42:69-74.
90. Todd RW, Etherington IJ, Lineseley DM The effects of 5% imiquimod cream on high grade VIN. Gynecol Oncol 2002, 85:67-70.
91. Townsend DE, et al. Management of vulvar intraepithelial neoplasia by carbon dioxide laser. Obstet Gynecol 1982, 60:49.
92. Van Beurden M, Van Der Vange N, Ten Kate FJW, et al. Restricted surgical management of vulvar intraepithelial neoplasia 3: Focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer 1998, 8:73.
93. Van Seters M, Fons G, van Beurden M Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study. J Reprod Med 2002, 47:501-505.
94. Van Seters M, van Beurden M, deCraen AJM Is the assumed natural history of VIN IV based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005, 97:645-651.
95. Woodruff JD, et al. The contemporary challenge of carcinoma in situ of the vulva. Am J Obstet Gynecol 1973, 115:677.